Etiological and Resistance Profile of Bacteria Involved in Urinary Tract Infections in Young Children

被引:22
作者
Sorlozano-Puerto, Antonio [1 ]
Maria Gomez-Luque, Jose [2 ]
de Dios Luna-del-Castillo, Juan [3 ]
Maria Navarro-Mari, Jose [4 ]
Gutierrez-Fernandez, Jose [1 ,4 ]
机构
[1] Univ Granada Ibs Granada, Dept Microbiol, Granada, Spain
[2] Complejo Hosp Univ Granada Ibs Granada, UGC Pediat, Hosp Gen Virgen de las Nieves, Granada, Spain
[3] Univ Granada Ibs Granada, Dept Bioestat, Granada, Spain
[4] Complejo Hosp Univ Granada Ibs Granada, Lab Microbiol, Hosp Gen Virgen de las Nieves, Granada, Spain
关键词
ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL SUSCEPTIBILITY; PATHOGENS;
D O I
10.1155/2017/4909452
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background. The objective of this study was to identify the bacteria most frequently responsible for urinary tract infection (UTI) in the population of under-2-year-olds in our geographic area and to evaluate the activity of antibiotics widely used for UTI treatment during a 4-year study period. Materials and Methods. A retrospective analysis was conducted of data on the identification and susceptibility of microorganisms isolated in urine samples from children under 2 years of age. Results. A total of 1,045 uropathogens were isolated. Escherichia coli accounted for the majority (60.3%) of these, followed by Enterococcus faecalis (22.4%) and Klebsiella spp. (6.5%). The highest E. coli susceptibility rates (>90%) were to piperacillin-tazobactam, cefuroxime, cefotaxime, ceftazidime, imipenem, gentamicin, nitrofurantoin, and fosfomycin, and the lowest were to amoxicillin-clavulanic acid and cotrimoxazole. Among all bacteria isolated, we highlight the overall high activity of piperacillin-tazobactam, imipenem, nitrofurantoin, and fosfomycin against both community and hospital isolates and the reduced activity of amoxicillin-clavulanic acid, cephalosporins, gentamicin, and cotrimoxazole. There was no significant change in the total activity of any of the studied antibiotics over the 4-year study period. Conclusion. Empiric treatment with amoxicillin-clavulanic acid, cotrimoxazole, cephalosporins, and gentamicin may be inadequate due to their limited activity against uropathogens in our setting.
引用
收藏
页数:8
相关论文
共 30 条
  • [1] Etiology and antimicrobial susceptibility among uropathogens causing community-acquired lower urinary tract infections:: A nationwide surveillance study
    Andreu, A
    Alós, JI
    Gobernado, M
    Marco, F
    de la Rosa, M
    García-Rodríguez, JA
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2005, 23 (01): : 4 - 9
  • [2] [Anonymous], BREAKP TABL INT MICS
  • [3] Community-acquired enterococcal urinary tract infections
    Bitsori, M
    Maraki, S
    Raissaki, M
    Bakantaki, A
    Galanakis, E
    [J]. PEDIATRIC NEPHROLOGY, 2005, 20 (11) : 1583 - 1586
  • [4] Clinical and Laboratory Standards Institute (CLSI), 2014, CLSI PUBL
  • [5] Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections
    Daza, R
    Gutiérrez, J
    Piédrola, G
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (03) : 211 - 215
  • [6] Eiros Bouza J M, 2007, An Pediatr (Barc), V67, P461
  • [7] In Vitro Activity of Fosfomycin against blaKPC-Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or Colistin
    Endimiani, Andrea
    Patel, Gopi
    Hujer, Kristine M.
    Swaminathan, Mahesh
    Perez, Federico
    Rice, Louis B.
    Jacobs, Michael R.
    Bonomo, Robert A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (01) : 526 - 529
  • [8] Urinary tract infections in hospital pediatrics: Many previous antibiotherapy and antibiotics resistance, including fluoroquinolones
    Garraffo, A.
    Marguet, C.
    Checoury, A.
    Boyer, S.
    Gardrat, A.
    Houivet, E.
    Caron, F.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2014, 44 (02): : 63 - 68
  • [9] Gutierrez J., 1989, ACTA PEDIAT ESP, V47, P159
  • [10] Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy
    Haller, M
    Brandis, M
    Berner, R
    [J]. PEDIATRIC NEPHROLOGY, 2004, 19 (09) : 982 - 986